{"id":22866,"date":"2016-07-07T12:43:26","date_gmt":"2016-07-07T11:43:26","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=22866"},"modified":"2016-07-07T12:43:26","modified_gmt":"2016-07-07T11:43:26","slug":"novetats-en-el-tractament-del-reflux-gastroesofagic","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/","title":{"rendered":"Novedades en el tratamiento del reflujo gastroesof\u00e1gico"},"content":{"rendered":"<p>El <b>reflujo gastroesof\u00e1gico<\/b> es el paso del contenido g\u00e1strico al es\u00f3fago, algo que se produce a diario de manera fisiol\u00f3gica sin que produzca s\u00edntomas ni patolog\u00eda digestiva. El efecto del \u00e1cido clorh\u00eddrico y la pepsina contenidas en el reflujo g\u00e1strico, sobre el epitelio esof\u00e1gico, pueden da\u00f1ar la barrera protectora y aumentar la permeabilidad de la mucosa. La enfermedad por reflujo gastroesof\u00e1gico (ERGE) es un conjunto de signos y s\u00edntomas causados por el contacto excesivo del contenido g\u00e1strico con la mucosa esof\u00e1gica. La <b>prevalencia actual <\/b>de esta patolog\u00eda <b>en Espa\u00f1a es del 31,6%<\/b>: tiene una evoluci\u00f3n cr\u00f3nica con per\u00edodos sintom\u00e1ticos con pirosis, dolor y regurgitaci\u00f3n \u00e1cida; s\u00edntomas menos caracter\u00edsticos como n\u00e1useas y v\u00f3mitos, epigastralgia, aerofagia; y s\u00edntomas m\u00e1s at\u00edpicos como tos cr\u00f3nica, broncospasmo, dolor tor\u00e1cico pseudoanginoso, laringitis, granulomas lar\u00edngeos o p\u00e9rdida del esmalte dentario.<\/p>\n<figure id=\"attachment_22870\" aria-describedby=\"caption-attachment-22870\" style=\"width: 260px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/06\/novetats-tractament-reflux-gastroesofagic-2.jpg\"><img decoding=\"async\" class=\"wp-image-22870\" alt=\"novetats-tractament-reflux-gastroesofagic (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/06\/novetats-tractament-reflux-gastroesofagic-2-1024x683.jpg\" width=\"260\" height=\"174\" \/><\/a><figcaption id=\"caption-attachment-22870\" class=\"wp-caption-text\">El doctor Serra en la conferencia que acogi\u00f3 el COFB<\/figcaption><\/figure>\n<p>En la conferencia \u201c<b>Reparaci\u00f3n del epitelio esof\u00e1gico. Un nuevo camino para el tratamiento del reflujo gastroesof\u00e1gico<\/b>\u201d, que acogi\u00f3 el COFB el 5 de mayo, el doctor <b>Jordi Serra<\/b>, jefe de la Unidad de Pruebas Funcionales Digestivas del Hospital Universitario Germans Trias y Pujol de Badalona, explic\u00f3 que actualmente disponemos de medicamentos que act\u00faan sobre la inhibici\u00f3n de la acidez g\u00e1strica como son los <b>anti\u00e1cidos<\/b>, los<b> antagonistas H2<\/b>, y los<b> inhibidores de la bomba de protones<\/b>. Por otro lado encontramos los <b>alginados<\/b>, que act\u00faan de forma mec\u00e1nica formando una barrera protectora en el est\u00f3mago para evitar el reflujo g\u00e1strico calmando el ardor en la boca de este \u00f3rgano.<\/p>\n<p>Ante los datos de los que <b>m\u00e1s del 30% de los pacientes con terapia con inhibidores de la bomba de protones no logran resolver los s\u00edntomas<\/b>, en esta conferencia se present\u00f3 un <b>nuevo medicamento <\/b>formado por tres componentes con tres acciones diferentes:<\/p>\n<ul>\n<li>el <b>sulfato de condroitina<\/b>, m\u00e1s abundante en los tejidos con una gran matriz extracelular (como los que forman los tejidos conectivos -cart\u00edlago, piel, vasos sangu\u00edneos, ligamentos y los tendones-) que ha demostrado protecci\u00f3n epitelial de la mucosa esof\u00e1gica protegiendo las \u00e1reas desepitelizadas de agresi\u00f3n \u00e1cida;<\/li>\n<li>el<b>\u00e1cido hialur\u00f3nico<\/b>, un constituyente esencial de la matriz extracelular de todos los tejidos animales -siendo especialmente abundante en los tejidos conectivos-, que ayuda a crear la trama de la matriz extracelular mediante sus interacciones con los proteoglicanos o el col\u00e1geno y que act\u00faa como reparador;<\/li>\n<li>y el <b>Polox\u00e1mero 407<\/b>, que forma con los dos anteriores un complejo macromolecular con actividad de barrera en la mucosa esof\u00e1gica prolongando la acci\u00f3n, una acci\u00f3n bioadhesiva termo-reversible, el fen\u00f3meno de termohielo es reversible caracterizado por una transici\u00f3n soluci\u00f3n\/hielo dependiendo de la temperatura, convirti\u00e9ndolo en un semis\u00f3lido con el aumento de temperatura. \u201cEsta combinaci\u00f3n no se ha asociado a efectos adversos graves, es bien tolerado y puede utilizarse en diab\u00e9ticos, intolerantes al gluten y la lactosa. Se presenta como un coadyuvante de los inhibidores de la bomba de protones (IBP) en la ERGE, tanto para adultos como para ni\u00f1os\u201d matiza <b>Merc\u00e8 Barau<\/b>, anterior vocal del COFB y coordinadora de esta formaci\u00f3n.<\/li>\n<\/ul>\n<p>Tras la presentaci\u00f3n se produjo un intenso debate sobre el nuevo medicamento y se plantearon preguntas sobre su actuaci\u00f3n y los ensayos cl\u00ednicos que tiene por el momento.<\/p>\n<p><a href=\"http:\/\/www.farmaceuticonline.com\/PDF\/consells_refluxgastroesofagicoregurcitacio.pdf\" target=\"_blank\" rel=\"noopener\">Ficha Reflujo gastroesof\u00e1gico o regurgitaci\u00f3n<\/a> (v\u00eda Farmaceuticonline)<\/p>\n<p style=\"text-align: right;\"><b><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/06\/novetats-tractament-reflux-gastroesofagic-1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"size-large wp-image-22869 aligncenter\" alt=\"novetats-tractament-reflux-gastroesofagic (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/06\/novetats-tractament-reflux-gastroesofagic-1-1024x546.jpg\" width=\"620\" height=\"330\" \/><\/a><br \/>\nCon la colaboraci\u00f3n de:<\/b><\/p>\n<p><b><a href=\"http:\/\/www.norgine.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignright  wp-image-22868\" alt=\"NORGINE\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/06\/NORGINE.jpg\" width=\"105\" height=\"79\" \/><\/a><\/b><\/p>","protected":false},"excerpt":{"rendered":"<p>El reflujo gastroesof\u00e1gico es el paso del contenido g\u00e1strico al es\u00f3fago, algo que se produce a diario de manera fisiol\u00f3gica sin que produzca s\u00edntomas ni patolog\u00eda digestiva. El efecto del \u00e1cido clorh\u00eddrico y la pepsina contenidas en el reflujo g\u00e1strico, sobre el epitelio esof\u00e1gico, pueden da\u00f1ar la barrera protectora y aumentar la [\u2026]<\/p>","protected":false},"author":1,"featured_media":22869,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[64,2432,2433,2434],"class_list":["post-22866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-farmaceutica","tag-malaltia-per-reflux-gastroesofagic","tag-mrge","tag-reflux-gastroesofagic"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novetats en el tractament del reflux gastroesof\u00e0gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novetats en el tractament del reflux gastroesof\u00e0gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El reflux gastroesof\u00e0gic \u00e9s el pas del contingut g\u00e0stric a l&#8217;es\u00f2fag, un fet que es produeix di\u00e0riament de manera fisiol\u00f2gica sense que produeixi s\u00edmptomes ni patologia digestiva. L&#8217;efecte de l&#8217;\u00e0cid clorh\u00eddric i la pepsina contingudes en el reflux g\u00e0stric, sobre l&#8217;epiteli esof\u00e0gic, poden danyar la barrera protectora i augmentar la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-07T11:43:26+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Novetats en el tractament del reflux gastroesof\u00e0gic\",\"datePublished\":\"2016-07-07T11:43:26+00:00\",\"dateModified\":\"2016-07-07T11:43:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/\"},\"wordCount\":619,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"malaltia per reflux gastroesof\u00e0gic\",\"MRGE\",\"reflux gastroesof\u00e0gic\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/\",\"name\":\"Novetats en el tractament del reflux gastroesof\u00e0gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-07-07T11:43:26+00:00\",\"dateModified\":\"2016-07-07T11:43:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novetats en el tractament del reflux gastroesof\u00e0gic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novetats en el tractament del reflux gastroesof\u00e0gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/","og_locale":"es_ES","og_type":"article","og_title":"Novetats en el tractament del reflux gastroesof\u00e0gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El reflux gastroesof\u00e0gic \u00e9s el pas del contingut g\u00e0stric a l&#8217;es\u00f2fag, un fet que es produeix di\u00e0riament de manera fisiol\u00f2gica sense que produeixi s\u00edmptomes ni patologia digestiva. L&#8217;efecte de l&#8217;\u00e0cid clorh\u00eddric i la pepsina contingudes en el reflux g\u00e0stric, sobre l&#8217;epiteli esof\u00e0gic, poden danyar la barrera protectora i augmentar la [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-07-07T11:43:26+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Novetats en el tractament del reflux gastroesof\u00e0gic","datePublished":"2016-07-07T11:43:26+00:00","dateModified":"2016-07-07T11:43:26+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/"},"wordCount":619,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","malaltia per reflux gastroesof\u00e0gic","MRGE","reflux gastroesof\u00e0gic"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/","url":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/","name":"Novetats en el tractament del reflux gastroesof\u00e0gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-07-07T11:43:26+00:00","dateModified":"2016-07-07T11:43:26+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/07\/novetats-en-el-tractament-del-reflux-gastroesofagic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Novetats en el tractament del reflux gastroesof\u00e0gic"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El reflux gastroesof\u00e0gic \u00e9s el pas del contingut g\u00e0stric a l&#8217;es\u00f2fag, un fet que es produeix di\u00e0riament de manera fisiol\u00f2gica sense que produeixi s\u00edmptomes ni patologia digestiva. L&#8217;efecte de l&#8217;\u00e0cid clorh\u00eddric i la pepsina contingudes en el reflux g\u00e0stric, sobre l&#8217;epiteli esof\u00e0gic, poden danyar la barrera protectora i augmentar la [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/22866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=22866"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/22866\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=22866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=22866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=22866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}